 | |
| Names | |
|---|---|
| IUPAC name (5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1,2,4,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | |
| Other names cholesta-8(9),24-dien-3-one; zymosterol intermediate 2[1] | |
| Identifiers | |
3D model (JSmol) | |
| ChEBI | |
| KEGG |
|
| |
| |
| Properties | |
| C27H42O | |
| Molar mass | 382.632 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Zymosterone is a syntheticanabolic steroid that has been studied for its potential use in veterinary medicine and as agrowth promoter in livestock. The compound is structurally related totestosterone and is known for its strong anabolic effects with relatively low androgenic activity.[2][3][4]
Zymosterone,NADPH and H(+) react to producezymosterol and NADP(+). This reaction takes place in theendoplasmic reticulum, catalyzed byHSD17B7.[5]
The conversion of zymosterone to zymosterol plays an important role in the synthesis ofergosterol, a crucial component for maintaining the structure and functionality of fungalcell membranes. Similar to how cholesterol functions in animal cells, ergosterol supports the membrane's stability and participates in multiple cellular activities.[6]
